Mood monitoring, as discussed in the mental health section, should be ongoing
These medication-specific considerations highlight the importance of tailoring treatment plans for vulnerable CKD populations
On average, patients lost up to 15% of their body weight , with some losing more than 20% , compared to only about 23% in the placebo group
90.8%), and/or chapping (n = 81
Tirzepatide , on the other hand, has a unique approval for addressing respiratory health
Combination with Insulin with or without Metformin In a 26-week double blind trial (Trial 6, NCT03021187), 731 adult patients with type 2 diabetes mellitus inadequately controlled on insulin (basal, basal/bolus or premixed) with or without metformin, were randomized to semaglutide tablets 3 mg, 7 mg and 14 mg orally once daily or placebo once daily